You are here: Industry Insights > HIV

News List

South Africa Ups Registration of New Pharmaceutical Products SHEM OIRERE
March 13, 2023
SAHPRA has recently announced completion of a review of 16,000 applications for new products and variations nearly four years after it took over from the former regulator, the Medicines Control Council.
The Last Ten Shanghai STAR Market Pharmaceutical IPOs David Orchard-Webb
March 16, 2022
The last ten biopharma companies that have IPO’d on the STAR Market (Shanghai Stock Exchange Science and Technology Innovation Board) are focused on oncology, synthetic biology, genomics, HIV & pain management...
How Much Do You Know About Fighting AIDS - An Overview of AIDS Cocktail Therapy PharmaSources/Xiaoyaowan
August 11, 2021
According to the data, the number of people infected with AIDS in the world reached 38 million in 2019, an increase of 1.88% year-on-year, including 1.7 million new cases.
Cabenuva HIV treatment approved for eight week dosing EuropeanPharmaceuticalReview
February 09, 2022
ViiV Healthcare has announced the US Food and Drug Administration’s (FDA) approval of Cabenuva (cabotegravir, rilpivirine) in the treatment of HIV.
Early research suggests Merck cancer drug may target dormant HIV ExpressPharma
January 29, 2022
Antiretroviral treatments now allow many HIV patients to lead normal lives, but the drugs do not completely remove the virus from the body
Injection of optimism as HIV vaccine trial begins pharmatimes
January 28, 2022
The first doses of an experimental HIV vaccine have been delivered in a phase 1 clinical trial. International AIDS Vaccine Initiative (IAVI), a non-profit scientific...
An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections Pharmaceutical-Technology
January 24, 2022
More than 1.2 million people - and potentially millions more - died in 2019 as a direct result of antibiotic-resistant bacterial infections, according to the most comprehensive estimate to date of the global impact of antimicrobial resistance (AMR).
Gates Foundation supports HIV and malaria research pharmatimes
January 15, 2022
Vir Biotech has launched a new antibody research initiative, expanding its partnership with the Bill & Melinda Gates Foundation to include the advancement of new innovations for HIV and malaria treatment.
FDA approves ViiV Healthcare’s Apretude for HIV prevention Pharmaceutical-Business-Review
December 22, 2021
The long-acting injectable is indicated for use in adults and adolescents who are at risk of sexually acquiring HIV and test negative for HIV-1 before initiation.
FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention FDA
December 22, 2021
Today, the U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents weighing at least 35 kilograms (77 pounds) for pre-exposure prophylaxis (PrEP)...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 24 25 Next page